{"id":55281,"date":"2023-03-28T23:04:33","date_gmt":"2023-03-28T21:04:33","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/"},"modified":"2023-03-28T23:04:33","modified_gmt":"2023-03-28T21:04:33","slug":"medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/","title":{"rendered":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023"},"content":{"rendered":"<div>\n<p>CINCINNATI&#8211;(BUSINESS WIRE)&#8211;Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/5\/Medpace_logo_tagline.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg\"><\/a><\/p>\n<p>\nTo participate in the conference call, interested parties must register in advance by clicking on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI2878c6fd0e0244fe8845f5f5f364343d&amp;esheet=53369315&amp;newsitemid=20230328005763&amp;lan=en-US&amp;anchor=this+link&amp;index=1&amp;md5=0d35250cc065bc7b97356046f71c2faa\" rel=\"nofollow noopener\" shape=\"rect\">this link<\/a>. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call.\n<\/p>\n<p>\nTo access the conference call via webcast, visit the \u201cInvestors\u201d section of Medpace\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finvestor.medpace.com%2F&amp;esheet=53369315&amp;newsitemid=20230328005763&amp;lan=en-US&amp;anchor=investor.medpace.com&amp;index=2&amp;md5=268ebff4af224fdbd46cd3ede386874a\" rel=\"nofollow noopener\" shape=\"rect\">investor.medpace.com<\/a>. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.\n<\/p>\n<p>\nA supplemental slide presentation will also be available at the \u201cInvestors\u201d section of Medpace\u2019s website prior to the start of the call.\n<\/p>\n<p>\n<b>About Medpace<\/b>\n<\/p>\n<p>\nMedpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace\u2019s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 5,200 people across 40 countries as of December 31, 2022.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nInvestor Contact:<br \/>\n<br \/>Lauren Morris<br \/>\n<br \/>513.579.9911 x11994<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;l&#x2e;&#109;o&#x72;&#114;i&#x73;&#64;m&#x65;&#100;&#x70;&#x61;&#99;&#x65;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#x2e;&#x6d;&#x6f;&#x72;&#x72;&#x69;&#x73;&#x40;&#x6d;&#x65;&#x64;&#x70;&#x61;&#x63;&#x65;&#x2e;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Julie Hopkins<br \/>\n<br \/>513.579.9911 x12627<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;&#116;&#x6f;&#58;j&#x2e;&#104;o&#x70;&#107;i&#x6e;&#115;&#64;&#x6d;&#101;&#x64;&#x70;&#97;&#x63;&#x65;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#x2e;&#104;&#x6f;p&#107;&#x69;&#110;&#x73;&#64;&#x6d;e&#100;&#x70;&#97;&#x63;e&#x2e;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CINCINNATI&#8211;(BUSINESS WIRE)&#8211;Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55281","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CINCINNATI&#8211;(BUSINESS WIRE)&#8211;Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-28T21:04:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023\",\"datePublished\":\"2023-03-28T21:04:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/\"},\"wordCount\":293,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005763\\\/en\\\/568207\\\/21\\\/Medpace_logo_tagline.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/\",\"name\":\"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005763\\\/en\\\/568207\\\/21\\\/Medpace_logo_tagline.jpg\",\"datePublished\":\"2023-03-28T21:04:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005763\\\/en\\\/568207\\\/21\\\/Medpace_logo_tagline.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230328005763\\\/en\\\/568207\\\/21\\\/Medpace_logo_tagline.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/","og_locale":"en_US","og_type":"article","og_title":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend","og_description":"CINCINNATI&#8211;(BUSINESS WIRE)&#8211;Medpace Holdings, Inc. (Nasdaq: MEDP) (\u201cMedpace\u201d) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to discuss these results. To participate in the conference ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-28T21:04:33+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023","datePublished":"2023-03-28T21:04:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/"},"wordCount":293,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/","url":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/","name":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg","datePublished":"2023-03-28T21:04:33+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230328005763\/en\/568207\/21\/Medpace_logo_tagline.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medpace-holdings-inc-to-report-first-quarter-2023-financial-results-on-april-24-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55281"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55281\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}